Floatz logo

Giapreza

Liver Cancer (Locally Advanced or Metastatic)

Niek WijnenPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

111 Active assets in the Liver Cancer (Locally Advanced or Metastatic) cohort.

Asset / SponsorPhaseRating
Bxcl501
Uppsala University Hospital
Phase 4BBB
Inno-206
Shanghai Zhongshan Hospital
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Idarubicine
Second Affiliated Hospital of Guangzhou Medical University
Phase 3BB

View all 50 →

Same molecule, other indications

Giapreza is also rated in:

disease related to solid organ transplantationDormant
BBB
Indicative ·
72 / 100
View asset →
acute kidney injuryDormant
BB
Indicative ·
70 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →